Additivity and non-additivity between dopamine-, norepinephrine-, carbachol- and GABA-stimulated GTPase activity

被引:18
作者
Odagaki, Y [1 ]
Dasgupta, S [1 ]
Fuxe, K [1 ]
机构
[1] KAROLINSKA INST,DEPT NEUROSCI,DIV CELLULAR & MOLEC NEUROCHEM,S-17177 STOCKHOLM,SWEDEN
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1995年 / 291卷 / 03期
关键词
dopamine D-2 receptor; muscarinic acetylcholine receptor; GABA(B) receptor; GTPase; receptor-G protein coupling; striatum;
D O I
10.1016/0922-4106(95)90064-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mode of coupling between neurotransmitter receptors and G proteins was investigated by agonist-induced high-affinity GTPase activity in rat striatal membranes. There was a simple additive relationship among dopamine-, carbachol-, and gamma-aminobutyric acid (GABA)-sensitive high-affinity GTPase activity in any combination, indicating that the respective receptors stimulated by these agonists (i.e., dopamine D-2, pirenzepine-insensitive muscarinic, and GABA(B) receptors) interact independently with distinct pools of G proteins. Unexpectedly non-additivity was observed between dopamine- and norepinephrine-stimulation. This lack of additivity was apparently due to stimulation of the same dopamine D-2 receptors by both dopamine and norepinephrine, since norepinephrine-stimulated high-affinity GTPase activity could be inhibited by dopaminergic but not adrenergic antagonists. The same non-additivity as seen in rat striatum was confirmed in the membranes prepared from cultured mouse fibroblast cells co-transfected with dopamine D-2 and adenosine A(2A) receptors. The implication of the (non-)additivity between receptor-mediated high-affinity GTPase activity was discussed with a consideration of the possible underlying molecular mechanism.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 36 条
[1]  
ANDRADE R, 1985, J NEUROSCI, V5, P2359
[2]   A-G PROTEIN COUPLES SEROTONIN AND GABA-B RECEPTORS TO THE SAME CHANNELS IN HIPPOCAMPUS [J].
ANDRADE, R ;
MALENKA, RC ;
NICOLL, RA .
SCIENCE, 1986, 234 (4781) :1261-1265
[3]  
BIMBAUMER L, 1969, J BIOL CHEM, V244, P3477
[4]   GABA-B RECEPTOR PHARMACOLOGY [J].
BOWERY, NG .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 :109-147
[5]  
BOWERY NG, 1989, ALLOSTERIC MODULATIO, P159
[6]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[7]   MUSCARINIC RECEPTORS - CHARACTERIZATION, COUPLING AND FUNCTION [J].
CAULFIELD, MP .
PHARMACOLOGY & THERAPEUTICS, 1993, 58 (03) :319-379
[8]  
COLLIS MG, 1993, TRENDS PHARMACOL SCI, V14, P360
[9]   CAMP-MEDIATED DECREASE IN K+ CONDUCTANCE EVOKED BY SEROTONIN AND DOPAMINE IN THE SAME NEURON - A BIOCHEMICAL AND PHYSIOLOGICAL SINGLE-CELL STUDY [J].
DETERRE, P ;
PAUPARDINTRITSCH, D ;
BOCKAERT, J ;
GERSCHENFELD, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7934-7938
[10]   RECENT ADVANCES IN THE MOLECULAR-BIOLOGY OF DOPAMINE-RECEPTORS [J].
GINGRICH, JA ;
CARON, MG .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :299-321